IC
RVMD icon

IEQ Capital’s Revolution Medicines RVMD Stock Holding History

IEQ Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Buy
58,834
+22,721
+63% +$3.32M 0.05% 325
2026
Q1 		$3.51M Sell
36,113
-11,299
-24% -$1.14M 0.02% 589
2025
Q4 		$3.78M Buy
47,412
+41,912
+762% +$2.75M 0.01% 602
2025
Q3 		$257K Buy
+5,500
New +$215K ﹤0.01% 1584
2025
Q1 		– Sell
-4,700
Closed -$206K – 1713
2024
Q4 		$206K Hold
4,700
– – ﹤0.01% 1199
2024
Q3 		$213K Buy
+4,700
New +$205K ﹤0.01% 1045

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

IEQ Capital's RVMD Position: Q2 2026 in Review

IEQ Capital increased its Revolution Medicines (RVMD) stake by 63% in Q2 2026, buying an estimated $3.32M and bringing the position to 58,834 shares worth $11M. The position accounts for 0.05% of the portfolio, ranked #325.

IEQ Capital first reported a position in RVMD in Q3 2024 and has held it in 6 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • IEQ Capital held 58,834 shares of Revolution Medicines worth $11M as of Q2 2026.
  • IEQ Capital bought 22,721 Revolution Medicines shares in Q2 2026, an estimated $3.32M.
  • Revolution Medicines made up 0.05% of IEQ Capital's portfolio in Q2 2026, its #325 holding.
  • IEQ Capital first reported a position in Revolution Medicines in Q3 2024 and has held it in 6 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.